Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
about
Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA.Loss of Dnmt3a and Dnmt3b does not affect epidermal homeostasis but promotes squamous transformation through PPAR-γA knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer dataChromatin Remodeling Factor LSH is Upregulated by the LRP6-GSK3β-E2F1 Axis Linking Reversely with Survival in Gliomas.Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways.The application of genome-wide 5-hydroxymethylcytosine studies in cancer research.The potential of DNA modifications as biomarkers and therapeutic targets in oncology.Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated TET1 expression.Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers.Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis.Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCCAberrant gene-specific DNA methylation signature analysis in cervical cancer.Epigenetic changes and functional study of HOXA11 in human gastric cancer.DNA immunoprecipitation semiconductor sequencing (DIP-SC-seq) as a rapid method to generate genome wide epigenetic signaturesLoss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer.Prostate cancer diagnosis using epigenetic biomarkers, 3D high-content imaging and probabilistic cell-by-cell classifiers.Cytosine 5-hydroxymethylation regulates VHL gene expression in renal clear cell carcinoma.Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemiaDecreased expression of ten-eleven translocation 2 protein is associated with progressive disease and death in patients with mycosis fungoides.Decrease in Lymphoid Specific Helicase and 5-hydroxymethylcytosine Is Associated with Metastasis and Genome Instability.Base resolution maps reveal the importance of 5-hydroxymethylcytosine in a human glioblastoma.Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.A Lexicon of DNA Modifications: Their Roles in Embryo Development and the Germline.The Progress of Methylation Regulation in Gene Expression of Cervical Cancer.Single-walled and multi-walled carbon nanotubes induce sequence-specific epigenetic alterations in 16 HBE cells.Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues.Epigenetic dysregulation of TET2 in human glioblastoma.DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancerExposure to Polycyclic Aromatic Hydrocarbons Leads to Non-monotonic Modulation of DNA and RNA (hydroxy)methylation in a Rat Model
P2860
Q33581992-3455B3C2-8624-4AFA-9A27-CDA85245654DQ33675655-D1F2E917-4624-49ED-874E-2C3CF0458504Q33750026-3ED7985A-F118-4575-BC0E-DC733D394718Q37541852-930C4C24-8E56-4197-8C72-974C50C46B33Q38379074-37A705B5-2648-4993-9A7D-F683C3D102BBQ38383659-C12DD6CD-5E33-4633-ACEC-4161074C81F0Q38591064-028D177D-20CD-4333-9BA0-3885B6736D73Q38715300-036B7FD7-E1AA-42C6-9364-05D50B43CB8CQ38738057-50A7B627-29D4-4C20-A2EA-2BD642AE0619Q38777365-6C766B04-7989-48A6-929F-C12B6965A8AEQ38785982-070F1B22-9512-484F-914C-A0586694D36FQ38802689-FBAC2368-2B5F-4EE3-8053-820404CB3AC7Q38870688-B9528BDF-444F-44F7-85FE-8E17766F2118Q38919802-B75B430F-0B56-40C0-AA7E-467742150E9DQ40768803-680D26C2-52BA-4BEA-88DC-0EC4F746E3F5Q41078250-DF5ADD6D-F59B-4D03-A12C-685492CC1788Q41342281-F4804025-A54D-4C29-9F86-9F234B4EB62EQ42362766-6714798E-4146-41C0-A481-0268F5C5102BQ42371573-F3EBA512-7200-4CEA-B458-B23B3EEECD05Q43955819-28E8040A-4CE0-421D-A39B-25FFAD4B8835Q44727719-20DC57C2-EED4-4C29-B949-BCD28DAF47EEQ47108059-B0ECC983-DB4E-4CEC-9F08-0B87D5AE46B2Q48132409-4B324B1A-86C8-4DC6-84AE-5B59366840A7Q52594988-5CC68D4F-3A87-4383-96C3-1E69A6CE396DQ54963071-58FE5D8A-7010-4403-A743-CE86DFCAD77AQ55008686-BB67418B-563F-4738-9E0F-7AD1407C32D5Q55254148-FDA694AF-B88A-4807-A780-3AE6C1FD3AF5Q55287120-07399C08-8C27-4B9E-948A-F131C98DEEDAQ56890318-F22F78FA-37CD-4F8E-9EC1-4E13026835FFQ57009882-29306D2C-3E8D-41FF-9F8F-206E9BF2B27E
P2860
Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
@en
type
label
Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
@en
prefLabel
Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
@en
P2860
P1433
P1476
Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
@en
P2093
Gabriella Ficz
John G Gribben
P2860
P304
P356
10.1016/J.YGENO.2014.08.017
P577
2014-08-30T00:00:00Z